You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 14, April 12, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Travel Medicine
 •Medical Practice
 •Medical Ethics
 •World Health
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Public Health Strategies for Pandemic Influenza

Ethics and the Law

Lawrence Gostin, JD, LLD

JAMA. 2006;295:1700-1704.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Highly pathogenic influenza A(H5N1) is endemic in avian populations in Southeast Asia, with serious outbreaks now in Africa, Europe, and the Middle East.1 Human cases, although rare, continue to increase, with high reported case-fatality rates. Industrialized countries place great emphasis on scientific solutions. The White House strategic plan and congressional appropriation both devote more than 90% of pandemic influenza spending to vaccines and antiviral medications.2 Yet, medical countermeasures, discussed in a previous JAMA Commentary, will not impede pandemic spread: experimental H5N1 vaccines may not be effective against a novel human subtype, neuraminidase inhibitors may become resistant, and medical countermeasures will be extremely scarce.3 This Commentary focuses on traditional public health interventions, drawing lessons from past influenza pandemics and the outbreaks of severe acute respiratory syndrome (SARS)4 (Table).


 
Table appears in full text version.
Table. Public Health Strategies—Public Benefits and Private Rights


Public health strategies are difficult to evaluate. First, evidence . . . [Full Text of this Article]

The Public Health System: Surveillance

Author Affiliation: Center for Law and the Public's Health, Georgetown University, Washington, DC, and Johns Hopkins University, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Moderate Pluralist Approach to Public Health Policy and Ethics
Selgelid
Public Health Ethics 2009;0:php018v1-php018.
ABSTRACT | FULL TEXT  

Effects of episodic variations in web-based avian influenza education: influence of fear and humor on perception, comprehension, retention and behavior
Kim et al.
Health Educ Res 2009;24:369-380.
ABSTRACT | FULL TEXT  

Who Should Receive Life Support During a Public Health Emergency? Using Ethical Principles to Improve Allocation Decisions
White et al.
ANN INTERN MED 2009;150:132-138.
ABSTRACT | FULL TEXT  

Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic
Markel et al.
JAMA 2007;298:644-654.
ABSTRACT | FULL TEXT  

Pandemic Influenza
Gunderman and Brown
Radiology 2007;243:629-632.
FULL TEXT  

Encouraging Compliance With Quarantine: A Proposal to Provide Job Security and Income Replacement
Rothstein and Talbott
AJPH 2007;97:S49-S56.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.